The Bayesian principle can we adapt?

Stroke

Volumn 36, Issue 7, 2005, Pages 1623-1624

  Donnan, Geoffrey A ^a   Davis, Stephen M ^a   Ludbrook, John ^a  

^a NONE

Author keywords

Bayes theorem; Clinical trials; Probability

Indexed keywords

BAYES THEOREM; CLINICAL TRIAL; NEUROPROTECTION; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL ANALYSIS; STROKE;

BAYES THEOREM; CLINICAL TRIALS; HUMANS; PROBABILITY; RESEARCH DESIGN; SAMPLE SIZE;

EID: 22044450753     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000170640.09580.fb     Document Type: Short Survey

References (4)

1. Fisher M; Stroke Therapy Academic Industry Roundtable. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke. 2003;34:1539-1546.
2. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA; ASTIN Study Investigators. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279 276 in acute ischemic stroke. Stroke. 2003;34:2543-2548.
3. AbESTT Investigators. Effects of abciximab for acute ischemic stroke: final results of the Abciximab in Emergency Stroke Treatment Trial (AbESTT). Stroke. 2003;34:253. Abstract.
4. Ludbrook J. Interim analyses of data as they accumulate in laboratory experimentation. BMC Med Res Methodol. 2003;3:15.